These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10573660

  • 1. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG, Bayon JE, González-Gallego J.
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [Abstract] [Full Text] [Related]

  • 2. The effect of physical conditioning on antipyrine clearance.
    Villa JG, Cuadrado G, Bayón JE, González-Gallego J.
    Eur J Appl Physiol Occup Physiol; 1998 Sep; 77(1-2):106-11. PubMed ID: 9459529
    [Abstract] [Full Text] [Related]

  • 3. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL, Tabernero B, García-López J, Jorquera F, Villa JG, González-Gallego J.
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [Abstract] [Full Text] [Related]

  • 4. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F, Almar M, Pozuelo M, Sansegundo D, González-Sastre M, González-Gallego J.
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [Abstract] [Full Text] [Related]

  • 5. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S, Nielsen AJ, Borg BE, Poulsen HE.
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [Abstract] [Full Text] [Related]

  • 6. Effect of age on the pharmacokinetics of antipyrine in calves.
    Janus K, Suszycka J.
    Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
    [Abstract] [Full Text] [Related]

  • 7. Antipyrine clearance and metabolite formation in primary biliary cirrhosis.
    Jorquera F, Almar M, Linares A, Olcóz JL, Rodrigo L, González-Gallego J.
    Dig Dis Sci; 2001 Feb; 46(2):352-9. PubMed ID: 11281185
    [Abstract] [Full Text] [Related]

  • 8. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K, Antoszek J.
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [Abstract] [Full Text] [Related]

  • 9. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW, Kampf D, Roots I, Vermeulen NP, Breimer DD.
    Eur J Clin Pharmacol; 1985 Jun; 28(5):589-95. PubMed ID: 4043202
    [Abstract] [Full Text] [Related]

  • 10. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
    Posner J, Danhof M, Teunissen MW, Breimer DD, Whiteman PD.
    Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV, Abul-Hajj Y, Awni WM.
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [Abstract] [Full Text] [Related]

  • 12. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR, Egan JM, Dickinson TH, Carrum G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [Abstract] [Full Text] [Related]

  • 13. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW, Spoelstra P, Koch CW, Weeda B, van Duyn W, Janssens AR, Breimer DD.
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [Abstract] [Full Text] [Related]

  • 14. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE, Alvinerie M, Pineau T, Boulard C, Galtier P.
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [Abstract] [Full Text] [Related]

  • 15. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
    Schellens JH, van der Wart JH, Danhof M, van der Velde EA, Breimer DD.
    Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
    [Abstract] [Full Text] [Related]

  • 16. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M.
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [Abstract] [Full Text] [Related]

  • 17. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW, van der Veen EA, Doodeman PJ, Breimer DD.
    Eur J Clin Pharmacol; 1984 Jun; 27(1):99-103. PubMed ID: 6489432
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH, Back DJ, Breckenridge AM, Howells RE.
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [Abstract] [Full Text] [Related]

  • 19. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ, Purba HS, Park BK, Ward SA, Orme ML.
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [Abstract] [Full Text] [Related]

  • 20. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D, Blevins R, Kerner N, Rubenfire M, Edwards DJ.
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.